Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Rangering i aksjer #14639
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Aksjekurs
$0.86562489
Markedsverdi
$402.47M
Endring (1 dag)
-1.27%
Endring (1 år)
56.02%
Land
SE
Handel Egetis Therapeutics AB (publ) (EGTX)

Kategori

Aksjeprishistorikk for Egetis Therapeutics AB (publ) (EGTX)
Høyeste sluttskurs: $0.87 den 2026-09-01

Laveste sluttskurs: $2.05 den 2011-04-01
Aksjeprishistorikk for Egetis Therapeutics AB (publ) fra 2011 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 16.98%
2025 -9.69%
2024 12.61%
2023 5.26%
2022 -32.21%
2021 -1.08%
2020 -64.01%
2019 24.17%
2018 -26.69%
2017 31.53%
2016 -66.48%
2015 78.45%
2014 56.36%
2013 68.37%
2012 3.47%
2011 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$747.04 4.70%
CH